Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Quoin Pharmaceuticals's total assets was $11.97M at Jun 30, 2026. For fiscal 2025 it was $20.39M, up 29.8% from the year before. The highest annual figure on record is $20.39M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.39M | +29.8% |
| FY2024 | Dec 31, 2024 | $15.71M | +29.1% |
| FY2023 | Dec 31, 2023 | $12.17M | -15.8% |
| FY2022 | Dec 31, 2022 | $14.46M | +54.5% |
| FY2021 | Dec 31, 2021 | $9.36M | +579.1% |
| FY2020 | Dec 31, 2020 | $1.38M | -77.7% |
| FY2019 | Dec 31, 2019 | $6.17M | -29.6% |
| FY2017 | Dec 31, 2017 | $8.76M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.97M | +34.3% |
| Q1 FY2026 | Mar 31, 2026 | $15.69M | +21.1% |
| Q4 FY2025 | Dec 31, 2025 | $20.39M | +29.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.42M | -43.6% |
| Q2 FY2025 | Jun 30, 2025 | $8.91M | -36.6% |
| Q1 FY2025 | Mar 31, 2025 | $12.96M | -19.6% |
| Q4 FY2024 | Dec 31, 2024 | $15.71M | +29.1% |
| Q3 FY2024 | Sep 30, 2024 | $11.39M | -24.4% |
| Q2 FY2024 | Jun 30, 2024 | $14.05M | -15.9% |
| Q1 FY2024 | Mar 31, 2024 | $16.12M | -12.6% |
| Q4 FY2023 | Dec 31, 2023 | $12.17M | -15.8% |
| Q3 FY2023 | Sep 30, 2023 | $15.07M | -8.3% |
| Q2 FY2023 | Jun 30, 2023 | $16.71M | +286.7% |
| Q1 FY2023 | Mar 31, 2023 | $18.45M | +97.2% |
| Q4 FY2022 | Dec 31, 2022 | $14.46M | +300.3% |
| Q3 FY2022 | Sep 30, 2022 | $16.44M | +1093.1% |
| Q2 FY2022 | Jun 30, 2022 | $4.32M | -30.0% |
| Q4 FY2021 | Dec 31, 2021 | $9.36M | +4.2% |
| Q2 FY2021 | Jun 30, 2021 | $3.61M | -58.8% |
| Q4 FY2020 | Dec 31, 2020 | $1.38M | – |
| Q4 FY2019 | Dec 31, 2019 | $6.17M | – |
| Q2 FY2018 | Jun 30, 2018 | $8.98M | – |
| Q4 FY2017 | Dec 31, 2017 | $8.76M | – |
See a number that looks wrong?